Table: Cosmos Pharmaceutical -2020/21 group results

Cosmos Pharmaceutical

12/07/2021 07:00

Jul 12 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2021    May 31, 2020   May 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          726.42          684.40         750.00        367.25   
               (+6.1 pct)      (+12.0 pct)                             
  Operating       33.15           29.09          33.20         16.20   
               (+13.9 pct)     (+17.4 pct)                             
  Recurring       35.84           31.56          35.90         17.46   
               (+13.5 pct)     (+15.6 pct)                             
  Net
  Net             27.16           21.44          25.00         11.87   
               (+26.7 pct)     (+11.7 pct)                             
  EPS          685.80 yen      541.30 yen     631.33 yen    299.83 yen 
  Ann Div       70.00 yen      110.00 yen      80.00 yen               
  -Q2 Div       27.50 yen       50.00 yen      40.00 yen               
  -Q4 Div       42.50 yen       60.00 yen      40.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T